MedTrace Logo

Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)

NCT02409511 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2017-07-25

No results posted yet for this study

Summary

Microalbuminuria (MA) is an independent cardiovascular risk factor in diabetic and non-diabetic subjects.

However, in the setting of type 2 diabetes, microalbuminuria could be a marker of either early diabetic nephropathy or diffuse endothelial dysfunction. At present, there are no biomarkers that permit us to discriminate between these two conditions.

Conditions

Interventions

OTHER

non intervention

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-09-30
Completion
2018-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02409511 on ClinicalTrials.gov